Avesthagen
From Wikipedia, the free encyclopedia
Located in Bangalore, India, Avesthagen (Avestha Gengraine Technologies) is a biotechnology and bioinformatics company focusing on food, pharmaceuticals, and nutraceuticals. Avesthagen was founded in 1998 and currently employs 215 people who focus on research with universities and pharmaceutical companies around the globe. This company has developed natural ingredients derived from plants, that are traditionally used in Indian medicine, and have been proven to be beneficial for conditions such as diabetes, obesity, and metabolic syndrome.
The company has successfully secured its first international patents and its subsidiary Avesthagen Quality Agriculture Services ("AQUAS") was an early leader in GMO testing in India.
Avesthagen opened a European office in Cambridge in 2004, securing deals that are said to have generated 35% of recent revenue.[1]
Dr Villoo Morawala Patell is the founder and CEO of the company.
[edit] Notes
- ^ India Economic News by Indian Embassy, The Netherlands, June 2006 p.11 accessed at [1] Oct 2, 2006. Avesthagen was also visited by the UK Government Science & Technology Minister in 2006 [2]
[edit] External links
- http://www.avesthagen.com
- Avesthagen to acquire two seed companies, The Hindu, Sep 10, 2006
- Avesthagen ties up with French seeds major, The Hindu Business Line, July 21, 2006
- Avesthagen to invest Rs 45 crore more, The Hindu Business Line, Oct 25, 2005
- Presentation by CEO, October 2003, at US-Asia Technology Management Center, Stanford University
- Avestha Gengraine gets US patents for multiple use tech, The Economic Times, Sep 10, 2003
This Indian corporation, company, Cooperative, NGO or Public Sector Undertaking article is a stub. You can help Wikipedia by expanding it.
